MedPath

Nanfang Hospital Southern Medical University

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

410

Active:6
Completed:64

Trial Phases

6 Phases

Early Phase 1:2
Phase 1:9
Phase 2:78
+3 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (249 trials with phase data)• Click on a phase to view related trials

Not Applicable
109 (43.8%)
Phase 2
78 (31.3%)
Phase 4
34 (13.7%)
Phase 3
17 (6.8%)
Phase 1
9 (3.6%)
Early Phase 1
2 (0.8%)

The Accuracy of Continuous Glucose Monitoring Systems in Critically Ill Patients

Completed
Conditions
Hyperglycemia in Critically Ill Patients
First Posted Date
2025-10-01
Last Posted Date
2025-10-01
Lead Sponsor
Nanfang Hospital, Southern Medical University
Target Recruit Count
55
Registration Number
NCT07201155
Locations
🇨🇳

Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China

PCSK9 Inhibitors in Acute Ischemic Stroke Patients Undergoing Endovascular Therapy

Not Applicable
Not yet recruiting
Conditions
Acute Ischemic Stroke
Interventions
Drug: PCSK9 inhibitor
First Posted Date
2025-09-15
Last Posted Date
2025-09-15
Lead Sponsor
Nanfang Hospital, Southern Medical University
Target Recruit Count
478
Registration Number
NCT07174375
Locations
🇨🇳

Fujian Medical University Union Hospital, Fuzhou, Fujian, China

🇨🇳

Dongguan Donghua Hospital, Dongguan, Guangdong, China

🇨🇳

Dongguan People's Hospital, Dongguan, Guangdong, China

and more 9 locations

Prospective Pathology Foundation Models

Recruiting
Conditions
Pancancer
First Posted Date
2025-09-05
Last Posted Date
2025-09-05
Lead Sponsor
Nanfang Hospital, Southern Medical University
Target Recruit Count
2000
Registration Number
NCT07157618
Locations
🇨🇳

Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China

🇨🇳

Qianfoshan Hospital, Jinan, Shandong, China

Immune Dynamics in the Natural History of Chronic HBV Infection

Recruiting
Conditions
HBV (Hepatitis B Virus)
HBV Infection
Chronic Hep B
First Posted Date
2025-08-22
Last Posted Date
2025-09-30
Lead Sponsor
Nanfang Hospital, Southern Medical University
Target Recruit Count
5000
Registration Number
NCT07137247
Locations
🇨🇳

Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China

A Randomized Controlled Study on the Improvement of Medical Experience for Patients With Radiation-induced Oropharyngeal Mucositis Based on the RIS System of the Internet of Things

Not Applicable
Not yet recruiting
Conditions
Radiation-Induced Mucositis
Head and Neck Cancer
First Posted Date
2025-08-17
Last Posted Date
2025-08-17
Lead Sponsor
Nanfang Hospital, Southern Medical University
Target Recruit Count
110
Registration Number
NCT07126457
Locations
🇨🇳

Nanfang hospital, Southern medical university, Guangzhou, Guangdong, China

🇨🇳

Huizhou Central People's Hospital, Huizhou, Guangdong, China

🇨🇳

Jieyang people's hospital, Jieyang, Guangdong, China

and more 1 locations
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 82
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.